Legislation Update

JurisdictionUnited States,Federal,California
CitationVol. 41 No. 2
Publication year2016
AuthorD. BENJAMIN BORSON
topicPatent law,Intellectual Property
Legislation Update

D. BENJAMIN BORSON

Borson Law Group

21 APRIL 2016
Disclaimer

This article does not constitute legal advice. It is intended solely for educational purposes relating to the general principles of the provisions discussed. If you have a particular legal issue, you may consult your attorney to ascertain the proper course of any action, based on the current law and the specific facts of your situation.

INTRODUCTION

Portions of this column were submitted as a part of the report to the Executive Committee, Intellectual Property Law Section of the State Bar of California. In this column, the author provides additional discussion of the Trans Pacific Partnership treaty (TPP), and of the newly passed Senate bill S.1890, the Defend Trade Secrets Act of 2016 (DTSA).

Much of the recent legislation is seemingly based on a continuing legislative path that began with the passage of the America Invents Act (AIA) in 2011.1 The AIA moved the United States into a regime of "First Inventor to File ("FITF")" and created new categories of USPTO procedures that permit challengers of a patent to replace or augment traditional litigation. Since the full implementation of the AIA in March 2013, many patents have been challenged, in particular, using the Patent Trial and Appeal Board (PTAB), Inter partes Review (or "IPR") and Covered Business Methods ("CBM") procedures. The PTAB has been quite active in adjudicating challenges under the CBM and IPR procedures, and many patents lost claims under 35 U.S.C. §101 for patent ineligibility.

PTAB proceedings differ from conventional district court trials in several important ways. First, based on the USPTO's own rulemaking authority, once a challenge under CBM or IPR has been approved by the Director, the presumption of patent validity is lost. As a result, a challenge to the validity of a patent claim must meet only the "preponderance of the evidence" evidentiary standard. Second, claims are construed by the PTAB based on the broadest reasonable interpretation.

In contrast, in a district court proceeding, to invalidate a patent claim, the burden on a challenger is "clear and convincing" evidence, and claim construction is based on the Federal Circuit decision in Phillips v. AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005), in which claims are construed based upon analysis of the plain language, the specification, the file history, and extrinsic evidence if needed.

These differences present potential litigants with important decisions. First, if a patentee sues in district court, the burden and claim construction would be handled under the Phillips standard. That is, in a district court proceeding, an issued patent claim would be presumed to be valid and a challenge to the patent claim would have to present "clear and convincing evidence" of invalidity. In contrast, a challenge to initiate as a PTAB proceeding, would face a very different standard. A patentee would have to defend its claim based on broadest reasonable interpretation without a presumption of validity.

In some cases, an existing district court proceeding can be stayed if the defendant files a petition for a Board Trial. This is similar to the well-known approach that many district court judges use to reduce their dockets. The court may require USPTO review of a patent prior to (or instead of) a full trial. A defendant may therefore litigate its case in a much more favorable jurisdiction, the PTAB.

CBMs and IPRs so far have addressed claim ineligibility based on an Abstract Idea for software, internet and other rapidly evolving technologies. However, there are some IPRs directed to invalidity challenges premised on "Natural Laws" based on the decision in Mayo v. Prometheus 566 U.S. ___, 132 S. Ct. 1289 (2012). It can be expected that other IPRs will be launched against the "Discovery" arts, including medical diagnostics. Although patent eligibility remains a hot topic for the PTAB and district courts, other grounds for invalidity are available for challengers to issued patent claims, including novelty under 35 U.S.C. § 102, obviousness under 35 U.S.C. § 103, and indefiniteness under 35 U.S.C.§ 112.

Although the Constitution and the Patent Act expressly recite "discoveries" as potentially patentable subject matter, the Courts have severely restricted patent eligibility, using "judicial exceptions," which, although without statutory or constitutional support, are grounded in the pre-constitutional doctrines arising from English law, namely the Statute of Monopolies. The Statute of Monopolies was one of the first articulated patent laws, being intended to support the then-existing new "industrial revolution" in England. Exactly how the Statute of Monopolies'" supports the current "judicial exceptions" is unclear and not further explored in this article.

Amid substantial controversy, patentees and defendants have invested substantial time and resources before the USPTO in adjudicating patent disputes. One conclusion reached by some innovators is to avoid the US patent system altogether, in favor of more "patentee friendly" jurisdictions, including Europe.

The U.S. Administration negotiated a new proposal, the Trans-Pacific Partnership Agreement ("TPP"). The TPP represents a vision of international cooperation in trade and importantly for IP professionals, patent law and its enforcement. The TPP has not been ratified by the Senate.

[Page 28]

With the decreased certainty of patent validity and enforceability, many are considering a return to protecting innovations through Trade Secrets. Some medical diagnostic companies are aware of the difficulty in obtaining and enforcing commercially valuable patent claims, and instead, develop diagnostic tests "in-house." For example, the successful challenge to the Prometheus patent was supported strongly by numerous well-known clinical laboratories, including Mayo itself.

With the trend toward increased use of trade secret protection, companies are developing strategies for protecting their proprietary information. Some companies use the current state law modeled on the "Uniform Trade Secret Act" or "UTSA." Now, the federal government has enacted the "Defend Trade Secret Act of 2016 ("DTSA").

The remainder of this article will briefly address the TPP and the DTSA.

TRANS-PACIFIC PARTNERSHIP AGREEMENT (TPP)

The Administration has negotiated a new agreement with many of the "Pacific Rim" countries. It has been submitted to the Senate for ratification. The Treaty is quite long, running to more than 100 pages...

Get this document and AI-powered insights with a free trial of vLex and Vincent AI

Get Started for Free

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex